Table 3.
Co-infections with Mycoplasma genitalium
| M. genitalium positive (N=41) n/N1 (%) | M. genitalium negative (N=678) n/N1 (%) | P value | Total population (N=719) | |
| Human papillomavirus, types 16 and 18 | 4/14 (28.6) | 43/281 (15.3) | 0.251 | 47/295 (15.9) |
| Bacterial vaginosis | 5/18 (27.8) | 98/340 (28.8) | 1.000 | 103/255 (28.8) |
| Trichomonas vaginalis | 7/40 (17.5) | 18/677 (2.7) | <0.001 | 25/717 (3.5) |
| Chlamydia trachomatis | 6/39 (15.4) | 54/670 (8.1) | 0.131 | 60/709 (8.5) |
| Neisseria gonorrhoeae | 0/39 (0) | 7/670 (1.0) | 1.000 | 7/709 (1.0) |
| Hepatitis B | 0/39 (0) | 2/637 (0.3) | 1.000 | 2/676 (0.3) |
| Hepatitis C | 0/17 (0) | 1/281 (0.4) | 1.000 | 1/298 (0.3) |
| Syphilis | 1/37 (2.7) | 8/639 (1.3) | 0.399 | 9/676 (1.3) |
| Herpes simplex virus 1/2 | 3/6 (50.0) | 23/104 (22.1) | 0.143 | 26/110 (23.6) |
| Group B Streptococcus | 7/12 (58.3) | 40/248 (16.1) | 0.002 | 47/260 (18.1) |
N1=number of women tested for the infection with a non-missing value. P value from Fisher’s exact test.